NaattuMarundhuKadai

India Founded: 2017 • Age: 9 yrs Listed
Online retailer of herbal medicines, Ayurvedic products, and health supplements.
Request Access
Report Incorrect Data
Page last updated

About NaattuMarundhuKadai

NaattuMarundhuKadai is a publicly listed company based in India founded in 2017. Online retailer of herbal medicines, Ayurvedic products, and health supplements. It operates on a B2C and D2C model in Agriculture and Healthcare sectors. The company has 288 employees. Its website naattumarundhukadai.com draws about 16 thousand monthly visits. Its Indian entity Sandu Pharmaceuticals Limited reported revenue of ₹70.37 Cr. NaattuMarundhuKadai offers products and services including Millet Noodles, Herbal Supplements, Ayurvedic Oils, and Herbal Tea. Its focus areas include Food and Agriculture Tech, Online Grocery, Health Foods and Millet Products.

Company details

Naattumarundhukadai operates as an online platform selling herbal supplements, Ayurvedic medicines, millet products, and personal care items. It focuses on natural health solutions like immunity boosters and lifestyle disease remedies. Based in India, it serves customers through e-commerce with options for fast delivery in Tamil Nadu and Bangalore, catering to individuals seeking traditional wellness products.

Operational Areas
Agriculture → Animal Feed & Nutrition
Healthcare → Alternative Medicine Products
Key Metrics
  • Market Cap
    ₹31.88 Cr

    SANDUPHQ · BSE

  • Share Price
    ₹33.99

    +3.00% today

  • Revenue
    ₹67.19 Cr

    FY 2024-25 · -0.1% YoY

  • EBITDA
    ₹2.77 Cr

    Margin 4.1%

  • Net Profit
    ₹1.56 Cr

    FY 2024-25 · +6.1% YoY

  • P/E (TTM)
    21.5x

    P/B 1.0x

  • ROE
    4.7%

    ROCE 6.9%

  • Employee Count
    288

Products & Services of NaattuMarundhuKadai

NaattuMarundhuKadai offers a comprehensive portfolio of products and services, including Millet Noodles, Herbal Supplements, Ayurvedic Oils, and Herbal Tea.

Millet Noodles
Food Products

Gluten-free noodles made from millets for healthy eating

Herbal Supplements
Health Supplements

Capsules and powders for boosting immunity and wellness

Ayurvedic Oils
Personal Care

Natural oils for hair and skin care needs

Herbal Tea
Beverages

Teas and drinks for daily health and digestion support

Board of directors of Sandu Pharmaceuticals Limited (NaattuMarundhuKadai)

Sandu Pharmaceuticals Limited is the primary company behind NaattuMarundhuKadai. The boards of the 2 registered companies of NaattuMarundhuKadai currently have 7 directors; the longest-serving is Ravindranath Bollineni, appointed in 2009. 11 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ravindranath Bollineni
DIN 02201405
Director22 Dec 200916 yrs 10 moNuzen Herbal Private Limited
Shashank Bhaskar Sandu
DIN 00678098
Director01 Jun 201115 yrs 4 moSandu Pharmaceuticals Limited
Chandana Bollineni
DIN 06362142
Director05 Oct 20179 yrsNuzen Herbal Private Limited
Balram Viswanathan
DIN 10245195
Director14 Aug 20233 yrs 2 moSandu Pharmaceuticals Limited
Ajit Rajaram Kantak
DIN 10269866
Director14 Aug 20233 yrs 2 moSandu Pharmaceuticals Limited
Vijay Kottapalli
DIN 10245156
Director12 Aug 20242 yrs 2 moSandu Pharmaceuticals Limited
Jayshree Bhasker Sandu
DIN 07480177
Director30 Sep 20242 yrsSandu Pharmaceuticals Limited

IPO & Listings of NaattuMarundhuKadai

NaattuMarundhuKadai is a publicly listed company on the BSE with ticker symbol SANDUPHQ in India, operating in the Pharmaceuticals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onBSE: SANDUPHQ
  • Listed entitySandu Pharmaceuticals Limited
  • Exchange sectorPharmaceuticals

Financials of NaattuMarundhuKadai

Exchange-reported figures of Sandu Pharmaceuticals Limited, the listed company behind NaattuMarundhuKadai (BSE: SANDUPHQ).

Financial Highlights

FY 2024-25 · Consolidated
Revenue
₹67.19 Cr
-0.1% YoY
EBITDA
₹2.77 Cr
+20.4% YoY
Profit After Tax
₹1.56 Cr
+6.1% YoY
Net Worth
₹42.02 Cr
+3.5% YoY
Total Assets
₹42.44 Cr
+4.4% YoY
Total Debt
Nil

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2024-25FY 2023-24FY 2022-23
Income statement
Revenue67.1967.2865.35
Revenue growth-0.1%+3.0%-
EBITDA2.772.302.48
EBITDA margin+4.1%+3.4%+3.8%
Profit before tax2.172.082.21
Net profit1.561.471.52
Net profit margin+2.3%+2.2%+2.3%
EPS (₹)1.611.511.57
Balance sheet
Total assets42.4440.6539.24
Net worth42.0240.5939.24
Total debt0.000.000.00
Cash & bank2.651.212.30
Net working capital14.2211.6711.66
Cash flow
Cash from operations0.950.760.22
Cash from investing(0.19)(1.31)0.54
Cash from financing(0.46)(0.72)0.58
ParticularsMar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Revenue14.0718.3717.7017.0515.6017.4316.6117.66
Revenue growth (YoY)-9.8%+5.4%+6.6%-3.5%+2.2%---
Other income0.070.020.030.040.310.030.090.00
EBITDA0.450.990.910.410.610.510.830.36
EBITDA margin+3.2%+5.4%+5.1%+2.4%+3.9%+2.9%+5.0%+2.0%
Depreciation0.150.190.170.160.190.140.130.12
Interest0.030.030.030.020.010.020.010.02
Profit before tax0.340.790.740.270.720.380.780.22
Tax0.010.240.240.110.120.170.210.10
Net profit0.330.550.500.160.600.210.570.12
EPS (₹)0.340.571.950.170.620.210.570.11
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue69.9367.1967.2865.3565.5058.7648.37
Revenue growth+4.1%-0.1%+3.0%-0.2%+11.5%+21.5%-
EBITDA2.992.762.302.482.882.151.45
EBITDA margin+4.3%+4.1%+3.4%+3.8%+4.4%+3.7%+3.0%
Profit before tax2.642.162.082.212.321.670.92
Net profit1.751.551.471.521.591.080.72
Net profit margin+2.5%+2.3%+2.2%+2.3%+2.4%+1.8%+1.5%
EPS (₹)1.831.601.511.581.801.381.02
Balance sheet
Total assets44.0942.4940.6639.2436.4733.5130.48
Net worth43.6742.0240.5939.2436.4733.4929.24
Total debt0.110.060.000.000.000.021.25
Cash & bank6.862.651.202.294.1711.661.54
Net working capital15.0114.2711.6611.6611.7718.0512.32
Cash flow
Cash from operations6.120.950.760.220.957.596.20
Cash from investing(0.57)(0.18)(1.31)0.53(5.47)(5.58)(0.37)
Cash from financing(0.94)(0.46)(0.72)0.580.931.30(5.36)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue16.3916.8518.7617.6216.7014.0718.3717.70
Revenue growth (YoY)-1.9%+19.8%+2.1%-0.5%-2.1%---
Other income0.020.370.010.050.020.070.020.03
Total expenses15.8516.2817.7216.7616.1713.6217.3816.79
EBITDA0.540.571.040.860.530.450.990.91
EBITDA margin+3.3%+3.4%+5.5%+4.9%+3.2%+3.2%+5.4%+5.1%
Depreciation0.160.160.170.170.180.150.190.17
Interest0.030.030.030.030.030.030.030.03
Profit before tax0.370.750.850.710.340.340.790.74
Tax0.130.70(0.12)0.190.120.010.240.24

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 24 Oct 2026
ParticularsMar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Revenue14.0718.3717.7017.0515.6017.4316.6117.66
Revenue growth (YoY)-9.8%+5.4%+6.6%-3.5%+2.2%---
Other income0.070.020.030.040.310.030.090.00
EBITDA0.450.990.910.410.610.510.830.36
EBITDA margin+3.2%+5.4%+5.1%+2.4%+3.9%+2.9%+5.0%+2.0%
Depreciation0.150.190.170.160.190.140.130.12
Interest0.030.030.030.020.010.020.010.02
Profit before tax0.340.790.740.270.720.380.780.22
Tax0.010.240.240.110.120.170.210.10
Net profit0.330.550.500.160.600.210.570.12
EPS (₹)0.340.571.950.170.620.210.570.11
ParticularsFY 2024-25FY 2023-24FY 2022-23
Revenue67.1967.2865.35
Revenue growth-0.1%+3.0%-
Other income0.170.420.33
Total expenses64.4264.9862.87
Employee cost10.9210.0711.10
EBITDA2.772.302.48
EBITDA margin+4.1%+3.4%+3.8%
Depreciation0.670.580.52
Interest0.100.060.08
Profit before tax2.172.082.21
Tax0.610.610.69
Net profit1.561.471.52
Net profit margin+2.3%+2.2%+2.3%
EPS (₹)1.611.511.57
ParticularsFY 2024-25FY 2023-24FY 2022-23
Equity & liabilities
Share capital9.669.669.66
Reserves & surplus32.3630.9329.58
Shareholders' funds (net worth)42.0240.5939.24
Minority interest0.000.000.00
Secured loans0.000.000.00
Unsecured loans0.000.000.00
Total debt0.000.000.00
Total liabilities42.4440.6539.24
Assets
Gross block30.2929.3527.51
Net block18.1517.8816.62
Capital work in progress0.000.000.42
Investments11.2210.429.65
Inventories14.1512.2514.33
Sundry debtors4.764.874.79
Cash & bank balances2.651.212.30
Loans & advances4.743.984.13
Total current assets26.3022.3125.55
Total current liabilities12.0810.6413.89
Net working capital14.2211.6711.66
Total assets42.4440.6539.24
ParticularsFY 2024-25FY 2023-24FY 2022-23
Opening cash1.002.280.94
Net cash from operating activities0.950.760.22
Net cash from investing activities(0.19)(1.31)0.54
Net cash from financing activities(0.46)(0.72)0.58
Net change in cash0.30(1.27)1.34
Closing cash2.651.212.30
ParticularsFY 2024-25FY 2023-24FY 2022-23
Growth
Sales growth-0.1%+3.0%-
EBITDA growth+20.4%-7.3%-
PBT growth+4.3%-5.9%+9997.0%
Net income growth+6.1%-3.3%-
Profitability & leverage
Net income margin+2.3%+2.2%+2.3%
Return on capital employed+6.9%+6.0%+5.9%
Return on net worth+4.7%+4.1%+3.9%
Debt / equity0.000.000.00
Long-term debt / equity0.000.000.00
Interest cover4.763.494.08
Efficiency & per share
Fixed asset turnover3.172.792.38
Inventory turnover5.095.064.56
Debtors turnover13.9513.9313.64
EPS (₹)1.611.511.57
Dividend per share (₹)0.800.800.00
Book value per share (₹)34.6333.0140.62
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue16.3916.8518.7617.6216.7014.0718.3717.70
Revenue growth (YoY)-1.9%+19.8%+2.1%-0.5%-2.1%---
Other income0.020.370.010.050.020.070.020.03
Total expenses15.8516.2817.7216.7616.1713.6217.3816.79
EBITDA0.540.571.040.860.530.450.990.91
EBITDA margin+3.3%+3.4%+5.5%+4.9%+3.2%+3.2%+5.4%+5.1%
Depreciation0.160.160.170.170.180.150.190.17
Interest0.030.030.030.030.030.030.030.03
Profit before tax0.370.750.850.710.340.340.790.74
Tax0.130.70(0.12)0.190.120.010.240.24
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue69.9367.1967.2865.3565.5058.7648.37
Revenue growth+4.1%-0.1%+3.0%-0.2%+11.5%+21.5%-
Other income0.440.170.420.330.080.190.45
Total expenses66.9464.4364.9862.8762.6256.6146.92
Employee cost10.6910.9210.0711.108.918.026.85
EBITDA2.992.762.302.482.882.151.45
EBITDA margin+4.3%+4.1%+3.4%+3.8%+4.4%+3.7%+3.0%
Depreciation0.680.670.580.520.530.560.55
Interest0.110.100.060.080.110.110.43
Profit before tax2.642.162.082.212.321.670.92
Tax0.890.610.610.690.730.590.20
Net profit1.751.551.471.521.591.080.72
Net profit margin+2.5%+2.3%+2.2%+2.3%+2.4%+1.8%+1.5%
EPS (₹)1.831.601.511.581.801.381.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital9.669.669.669.668.817.927.08
Reserves & surplus34.0132.3630.9329.5827.2224.6722.16
Shareholders' funds (net worth)43.6742.0240.5939.2436.4733.4929.24
Secured loans0.000.000.000.000.000.021.25
Unsecured loans0.110.060.000.000.000.000.00
Total debt0.110.060.000.000.000.021.25
Total liabilities44.0942.4940.6639.2436.4733.5130.48
Assets
Gross block30.9630.2929.3527.5126.3826.0225.89
Net block18.1218.1517.8816.6216.0116.1816.60
Capital work in progress0.060.000.000.420.480.000.00
Investments12.3011.2210.439.669.110.240.82
Inventories10.4714.1512.2514.3311.2711.1414.36
Sundry debtors5.414.764.874.793.995.354.68
Cash & bank balances6.862.651.202.294.1711.661.54
Loans & advances2.594.743.984.134.212.401.83
Total current assets25.3326.3022.3025.5423.6430.5522.41
Total current liabilities10.3212.0310.6413.8811.8712.5010.09
Net working capital15.0114.2711.6611.6611.7718.0512.32
Total assets44.0942.4940.6639.2436.4733.5130.48
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1.301.002.270.944.531.220.74
Net cash from operating activities6.120.950.760.220.957.596.20
Net cash from investing activities(0.57)(0.18)(1.31)0.53(5.47)(5.58)(0.37)
Net cash from financing activities(0.94)(0.46)(0.72)0.580.931.30(5.36)
Net change in cash4.600.31(1.27)1.33(3.59)3.310.48
Closing cash6.862.651.202.294.1711.661.54
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+4.1%-0.1%+3.0%-0.2%+11.5%+21.5%-
EBITDA growth+8.3%+20.0%-7.3%-13.9%+34.0%+48.3%-
PBT growth+22.2%+3.9%-5.9%-4.7%+38.9%+81.5%-8.0%
Net income growth+12.9%+5.4%-3.3%-4.4%+47.2%+50.0%-
Revenue CAGR (3Y)+2.3%+0.9%+4.6%+10.6%+9.8%+6.2%+4.2%
EBITDA CAGR (3Y)+6.4%-1.4%+2.3%+19.6%+11.5%-4.4%-7.8%
Profitability & leverage
Net income margin+2.5%+2.3%+2.2%+2.3%+2.4%+1.8%+1.5%
Return on capital employed+8.0%+6.9%+6.0%+6.9%+9.4%+7.9%+4.8%
Return on net worth+5.2%+4.7%+4.1%+4.6%+6.1%+4.9%+3.0%
Debt / equity0.000.000.000.000.000.030.15
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover4.764.783.494.084.686.9247.78
Efficiency & per share
Fixed asset turnover3.163.172.792.913.823.502.28
Inventory turnover5.685.095.065.115.854.613.50
Debtors turnover13.7513.9513.9314.8914.0311.7210.20
EPS (₹)1.831.601.511.581.801.381.02
Dividend per share (₹)0.000.800.800.000.750.500.00
Book value per share (₹)36.4834.6233.0140.6230.7129.6328.22

Web traffic of NaattuMarundhuKadai

The website of NaattuMarundhuKadai (naattumarundhukadai.com) receives about 16.5K visits a month and ranks #1,240,340 among all websites worldwide, #1,399 in Alternative and Natural Medicine.

  • Monthly visits
    16.5K

    ▼ 29.6% vs previous month

  • Unique visitors
    14K

    per month

  • Global rank
    #1,240,340

    among all websites

  • Category rank
    #1,399

    Health · Alternative and Natural Medicine

Similar websites

Websites whose visitors overlap most with NaattuMarundhuKadai. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Health Potli
healthpotli.com
51%
75.5K#445,741View details

Top companies in Animal Feed & Nutrition

3 companies that operate in the same segment as NaattuMarundhuKadai (Animal Feed & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Karnataka Cooperative Milk Producers Federation
Procures and distributes milk and dairy products through unions and online orders.
1984Bengaluru, Karnataka, IndiaUSD 2.58 M
Gyan Dairy
A brand specializing in high-quality milk and food products.
2007Lucknow, Uttar Pradesh, IndiaUSD 184.73 M1,016
Too Yumm
Provides healthy snack options including potato chips, multigrain chips, and noodles for consumers.
2016Kolkata, West Bengal, IndiaUSD 51.28 M388
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Naattumarundhukadai

Sandu Pharmaceuticals standalone net profit rises 4.55% in the June 2026 quarter | Capital Market News - Business Standard
Business Standard • 2 months ago
SANDUPHQ: Q1 FY27 revenue reached ₹1,638.88 lakhs with net profit at ₹22.82 lakhs and EPS at ₹0.37
Quartr • 2 months ago
SANDUPHQ: FY26 saw higher revenue, profit, and cash, with a Rs. 1 dividend and no large borrowings
Quartr • 5 months ago
SANDUPHQ: Revenue and profit rose, dividend declared, and new leadership and auditor appointed
Quartr • 5 months ago
SANDUPHQ: Q3 FY26 saw higher revenue and profit, with EPS at ₹1.01 and a single-segment focus
Quartr • 8 months ago
SANDUPHQ: Q2 FY26 saw higher revenue, improved profit, and robust cash flow in Ayurvedic medicines
Quartr • 11 months ago
SANDUPHQ: Q1 FY26 saw higher revenue and profit, with AGM and dividend record date set for September
Quartr • 1 year ago
Sandu Pharmaceuticals consolidated net profit declines 44.07% in the March 2025 quarter | Capital Market News - Business Standard
Business Standard • 1 year ago
SANDUPHQ: FY25 saw steady profit growth, a dividend proposal, and a shift to standalone reporting
Quartr • 1 year ago
SANDUPHQ: Net profit rose 4.02% to ₹154.89 lakhs on stable revenue; 8% dividend recommended
Quartr • 1 year ago
Premium access

Complete news archive for NaattuMarundhuKadai

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NaattuMarundhuKadai

NaattuMarundhuKadai was founded in 2017.

NaattuMarundhuKadai is headquartered in India.

NaattuMarundhuKadai has 288 employees.

The primary company behind NaattuMarundhuKadai, Sandu Pharmaceuticals Limited, reported revenue of ₹70.37 Cr for FY 2026, up 4% year on year.

Naattumarundhukadai operates as an online platform selling herbal supplements, Ayurvedic medicines, millet products, and personal care items. It focuses on natural health solutions like immunity boosters and lifestyle disease remedies. Based in India, it serves customers through e-commerce with options for fast delivery in Tamil Nadu and Bangalore, catering to individuals seeking traditional wellness products.

NaattuMarundhuKadai offers Millet Noodles, Herbal Supplements, Ayurvedic Oils, and Herbal Tea.

Yes, NaattuMarundhuKadai is publicly traded on BSE under the ticker symbol SANDUPHQ.

NaattuMarundhuKadai is associated with 2 legal entities: Sandu Pharmaceuticals Limited, Nuzen Herbal Private Limited.

The legal entities of NaattuMarundhuKadai currently have 10 directors, including Shashank Bhaskar Sandu, Pratika Mhambray, Jayshree Bhasker Sandu and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available